Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

CS CALCULATI CL

Diseases
Sclerotinia, Phomosis
Country
France
Registration Year
2023
Manufacturer
Lidea
Offers: 3
Where to buy
Price range
520 - 7 690 UAH
Views
13
Reviews
0
Producer
Lidea
Description CS CALCULATI CL
CS CALCULATI CL — this is an autumn rapeseed hybrid from the Clearfield® segment, developed by breeders of the company Lidea. It is characterized by high yield and resistance to the herbicide Eurolightning, which allows effective weed control and stable results even at late sowing dates. The hybrid has a medium maturity period and is suitable for cultivation in various climatic zones of Ukraine, including steppe, forest-steppe, and lowland areas.

Plants of this hybrid are characterized by high stature, medium-late flowering, and good resistance to major diseases such as phomopsis and sclerotinia. Due to its tolerance to phomopsis, there is less need for fungicide applications, which allows cost savings on crop protection. Moreover, the hybrid demonstrates high winter hardiness, resistance to lodging, and resistance to pod cracking, which contributes to maintaining yield and quality.

Oil content in seeds reaches 47%, making this hybrid attractive for high-quality oil production. The recommended plant density at harvest is 35–45 thousand per hectare, ensuring optimal land use and maximum productivity. CS CALCULATI CL is a reliable choice for farmers aiming for high yields and quality raw material under various agroclimatic conditions.
Specifications CS CALCULATI CL
Diseases
Sclerotinia
Sclerotiniosis
Phomosis
Phomosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Growing Season
120-130 days
Yield Potential
60-70 ц/га
Herbicide Resistance
Clearfield
Plant: height
160-170 cm
Oil Content
45-50%
Plant: Branching
Average
Flowering Duration
30-40 days
Country
France
Registration Year
2023
Catalog
Varieties
Technical Crops
Manufacturer
Lidea
Where to buy CS CALCULATI CL
Loading...
Reviews CS CALCULATI CL
0comments
Sort by:Popular first
No comments yet.